Latest1 information on COVID-19
©2022 Stanford Medicine
PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation
Recruiting
Trial ID: NCT02475798
Purpose
The purpose of this extended study is to collect confirmatory safety and effectiveness data
on the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the
commercially available Atrium iCAST™ covered stent in the treatment of aortoiliac and iliac
aneurysms.
Official Title
Clinical Study to Collect Confirmatory Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation
Stanford Investigator(s)
Jason T. Lee, MD
Professor of Surgery (Vascular Surgery)
Eligibility
Inclusion Criteria:
- An aortoiliac or iliac aneurysm of appropriate size
- Unsuitable distal sealing site for a traditional Zenith® iliac leg graft within the
common iliac artery
Exclusion Criteria:
- Less than 18 years of age
- Inability or refusal to give informed consent
- Disease considerations that would compromise patient safety or study outcomes
- Unsuitable arterial anatomy
Intervention(s):
device: Zenith® Branch Endovascular Graft-Iliac Bifurcation,
Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305